SenzaGen Revenue and Competitors
Estimated Revenue & Valuation
- SenzaGen's estimated annual revenue is currently $3.7M per year.
- SenzaGen's estimated revenue per employee is $155,000
Employee Data
- SenzaGen has 24 Employees.
- SenzaGen grew their employee count by -11% last year.
SenzaGen's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP Operations | Reveal Email/Phone |
2 | Key Account Manager | Reveal Email/Phone |
SenzaGen Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is SenzaGen?
SenzaGen is a Swedish in vitro test lab company which offers animal-free testing of chemical compounds using genomics-based methodology for immunotoxicological assays. Our proprietary lead product family, GARD, potentially replaces the need for animal testing in the cosmetic, chemical and pharmaceutical industries. GARD utilizes genomic biomarker signatures of hundreds of genes relevant for hazard prediction. Doing so, it predicts and classifies chemical sensitizers with superior predictive accuracy. A dermal test (GARDskin) is commercially available on the market through the lab at headquarters in Lund and distributors in the US. The R&D of SenzaGen is founded on a deep know-how of the immune system and its reaction to hazardous agents, such as irritants and allergens. The company was formed in 2010 as a spin-out from the research being performed at the Department of Immunotechnology at the Faculty of Engineering, Lund University.
keywords:N/A
N/A
Total Funding
24
Number of Employees
$3.7M
Revenue (est)
-11%
Employee Growth %
N/A
Valuation
N/A
Accelerator
SenzaGen News
... Atomo Diagnostics, SenzaGen, Exalenz Biosciences Ltd., Nanomedical Diagnostics, BGN Technologies, Mesa Biotech Inc., and Millar, Inc.
... Inc. Atomo Diagnostics; SenzaGen; Exalenz Biosciences Ltd. Nanomedical Diagnostics; BGN Technologies; Mesa Biotech Inc.,; Millar Inc.
Other Companies in Lund
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $5.9M | 24 | 4% | N/A |
#2 | $3.4M | 24 | -27% | N/A |
#3 | $1.8M | 25 | 4% | N/A |
#4 | $2.4M | 26 | -19% | N/A |
#5 | $6.8M | 27 | 0% | N/A |